Fundamental index

RGEN Repligen Corporation

Healthcare · Medical - Instruments & Supplies · US · as of 2026-07-29

D
Fundamental score
47.78

Reasons

  • Balance 100: debt/equity n/a, current ratio 9.20, Altman Z 7.09
  • Quality 32: ROE 2.5%, ROIC n/a, net margin 6.7%
  • Valuation 31: PE n/a, EV/EBITDA n/a, FCF yield 1.3%

Risk flags

No major cached red flags

Component scores

Quality32
Growth50
Balance100
Valuation31
Cash flow21

Key metrics

ROE
2.5% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
ROICn/a
Net margin
6.7% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
Revenue growthn/a
Debt / equityn/a
Current ratio
9.20 above 1 is generally healthier
03+
risk < 1.0ok >= 1.0strong >= 2.0
Altman Z-score
7.09 higher usually means lower distress risk
04+
distress < 1.8grey 1.8-3.0safer > 3.0
PE ration/a
EV / EBITDAn/a
FCF yield
1.3% higher cash-flow yield is usually better
-5%15%+
weak < 0%ok >= 3%strong >= 8%

Revenue

801.54M 194.03M 194.03M 270.25M 366.26M 670.53M 801.54M 632.36M 634.44M 738.26M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: revenue values.

Net income

185.96M -25.51M 16.62M 21.41M 59.93M 128.29M 185.96M 35.60M -25.51M 48.89M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: net income values.

Free cash flow

142.49M 18.73M 18.73M 44.06M 36.28M 51.93M 38.74M 74.93M 142.49M 93.90M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: free cash flow values.

Growth metrics

83.1% -21.1% 37.4% 39.3% 35.5% 83.1% 19.5% -21.1% 0.3% 16.4% 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: growth metrics values.

Abbreviations and definitions

ROE
ROE measures how much net profit a company generates from shareholders' equity.
ROIC
ROIC compares operating profit after tax with the capital invested in the business.
Net margin
Net margin shows how much net profit remains from revenue.
Revenue growth
Revenue growth measures how sales changed versus the comparable prior period.
Debt / equity
Debt to equity compares company debt with shareholders' equity.
Current ratio
Current ratio compares short-term assets with short-term liabilities.
Altman Z-score
Altman Z-score is a model estimating bankruptcy risk from financial ratios.
PE ratio
PE compares market price with earnings per share.
EV / EBITDA
EV/EBITDA compares total company value with operating earnings before depreciation and amortization.
FCF yield
FCF yield compares free cash flow with market value.
Revenue
Revenue is the total amount generated from selling goods or services before expenses.
Net income
Net income is profit after operating costs, interest, taxes and other expenses.
Free cash flow
Free cash flow is cash left after operating cash flow covers capital expenditures.
Growth metrics
Growth metrics summarize changes in revenue, profit or EPS versus a prior period.
EPS
EPS is net income allocated to each share.
EBITDA
EBITDA is earnings before interest, taxes, depreciation and amortization.
TTM
TTM is a rolling last-12-month view instead of one fiscal year.

This page is an automated factual summary of cached FMP data, not investment advice. Always verify source filings and liquidity before making decisions.